Issue 3, 2021

Proteolysis targeting chimeras (PROTACs) come of age: entering the third decade of targeted protein degradation

Abstract

With the discovery of PROteolysis TArgeting Chimeras (PROTACs) twenty years ago, targeted protein degradation (TPD) has changed the landscape of drug development. PROTACs have evolved from cell-impermeable peptide-small molecule chimeras to orally bioavailable clinical candidate drugs that degrade oncogenic proteins in humans. As we move into the third decade of TPD, the pace of discovery will only accelerate. Improved technologies are enabling the development of ligands for “undruggable” proteins and the recruitment of new E3 ligases. Moreover, enhanced computing power will expedite identification of active degraders. Here we discuss the strides made in these areas and what advances we can look forward to as the next decade in this exciting field begins.

Graphical abstract: Proteolysis targeting chimeras (PROTACs) come of age: entering the third decade of targeted protein degradation

Article information

Article type
Review Article
Submitted
13 1月 2021
Accepted
11 3月 2021
First published
19 3月 2021
This article is Open Access
Creative Commons BY-NC license

RSC Chem. Biol., 2021,2, 725-742

Proteolysis targeting chimeras (PROTACs) come of age: entering the third decade of targeted protein degradation

M. J. Bond and C. M. Crews, RSC Chem. Biol., 2021, 2, 725 DOI: 10.1039/D1CB00011J

This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence. You can use material from this article in other publications, without requesting further permission from the RSC, provided that the correct acknowledgement is given and it is not used for commercial purposes.

To request permission to reproduce material from this article in a commercial publication, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party commercial publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements